163 related articles for article (PubMed ID: 27258561)
1. Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 Deficiency.
Xia M; Singhi AD; Dudley B; Brand R; Nikiforova M; Pai RK
Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):399-406. PubMed ID: 27258561
[TBL] [Abstract][Full Text] [Related]
2. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
Kaya M; Post CCB; Tops CM; Nielsen M; Crosbie EJ; Leary A; Mileshkin LR; Han K; Bessette P; de Boer SM; Jürgenliemk-Schulz IM; Lutgens L; Jobsen JJ; Haverkort MAD; Nout RA; Kroep J; Creutzberg CL; Smit VTHBM; Horeweg N; van Wezel T; Bosse T
Mod Pathol; 2024 Mar; 37(3):100423. PubMed ID: 38191122
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.
Kato MK; Fujii E; Asami Y; Momozawa Y; Hiranuma K; Komatsu M; Hamamoto R; Ebata T; Matsumoto K; Ishikawa M; Kohno T; Kato T; Yoshida H; Shiraishi K
Cancer Sci; 2024 May; 115(5):1646-1655. PubMed ID: 38433331
[TBL] [Abstract][Full Text] [Related]
4. The utility of evaluating mismatch repair proteins in endometrial carcinoma: an experience from a tertiary referral centre in North India.
Jain E; Prasad S; Dhar A; Kini L; Sharma S; Dewan A
Pathologica; 2021 Apr; 113(2):115-120. PubMed ID: 34042092
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer.
Post CCB; Stelloo E; Smit VTHBM; Ruano D; Tops CM; Vermij L; Rutten TA; Jürgenliemk-Schulz IM; Lutgens LCHW; Jobsen JJ; Nout RA; Crosbie EJ; Powell ME; Mileshkin L; Leary A; Bessette P; Putter H; de Boer SM; Horeweg N; Nielsen M; Wezel TV; Bosse T; Creutzberg CL
J Natl Cancer Inst; 2021 Sep; 113(9):1212-1220. PubMed ID: 33693762
[TBL] [Abstract][Full Text] [Related]
6. Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis.
Mitric C; Salman L; Abrahamyan L; Kim SR; Pechlivanoglou P; Chan KKW; Gien LT; Ferguson SE
Gynecol Oncol; 2023 Mar; 170():133-142. PubMed ID: 36682091
[TBL] [Abstract][Full Text] [Related]
7. Universal screening for Lynch syndrome in operated colorectal cancer by immunohistochemistry: a cohort of patients in Liaoning province, China.
Zhao G; Xiang G; Hu X; Qiao Y; Ma S; Tian Y; Gao X; Liu F; Li X; Shi G
Eur J Cancer Prev; 2023 Jul; 32(4):337-347. PubMed ID: 36942852
[TBL] [Abstract][Full Text] [Related]
8. Identification of Lynch Syndrome Carriers among Patients with Small Bowel Adenocarcinoma.
Sánchez A; Bujanda L; Cuatrecasas M; Bofill A; Alvarez-Urturi C; Hernandez G; Aguilera L; Carballal S; Llach J; Herrera-Pariente C; Iglesias M; Rivero-Sánchez L; Jung G; Moreno L; Ocaña T; Bayarri C; Pellise M; Castells A; Castellví-Bel S; Balaguer F; Moreira L
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944998
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status.
de Freitas D; Aguiar FN; Anton C; de Almeida DC; Bacchi CE; Carvalho JP; Carvalho FM
Heliyon; 2023 Jun; 9(6):e17495. PubMed ID: 37408903
[TBL] [Abstract][Full Text] [Related]
10. Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome.
Schwartz CJ; da Silva EM; Marra A; Gazzo AM; Selenica P; Rai VK; Mandelker D; Pareja F; Misyura M; D'Alfonso TM; Brogi E; Drullinsky P; Razavi P; Robson ME; Drago JZ; Wen HY; Zhang L; Weigelt B; Shia J; Reis-Filho JS; Zhang H
Clin Cancer Res; 2022 Jan; 28(2):404-413. PubMed ID: 34667028
[TBL] [Abstract][Full Text] [Related]
11. Universal Immunohistochemistry for Lynch Syndrome: A Systematic Review and Meta-analysis of 58,580 Colorectal Carcinomas.
Eikenboom EL; van der Werf-'t Lam AS; Rodríguez-Girondo M; Van Asperen CJ; Dinjens WNM; Hofstra RMW; Van Leerdam ME; Morreau H; Spaander MCW; Wagner A; Nielsen M
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e496-e507. PubMed ID: 33887476
[TBL] [Abstract][Full Text] [Related]
12. Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis.
Aiyer KTS; Doeleman T; Ryan NA; Nielsen M; Crosbie EJ; Smit VTHBM; Morreau H; Goeman JJ; Bosse T
Mod Pathol; 2022 Dec; 35(12):1775-1783. PubMed ID: 36104536
[TBL] [Abstract][Full Text] [Related]
13. Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience.
Pauly N; Baert T; Schmutzler R; du Bois A; Schneider S; Rhiem K; Schömig-Markiefka B; Siemanowski J; Heikaus S; Traut A; Heitz F; Prader S; Ehmann S; Harter P; Ataseven B
Arch Gynecol Obstet; 2021 Oct; 304(4):975-984. PubMed ID: 33710393
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical screening for mismatch repair protein deficiency in paediatric high-grade gliomas - institutional experience and review of literature.
Alphones S; Chatterjee U; Singh A; Das A; Zameer L; Achari R; Bhattacharya A; Roy P
Childs Nerv Syst; 2021 Aug; 37(8):2521-2530. PubMed ID: 34097097
[TBL] [Abstract][Full Text] [Related]
15. Molecular Heterogeneity of High Grade Colorectal Adenocarcinoma.
Perna C; Navarro A; Ruz-Caracuel I; Caniego-Casas T; Cristóbal E; Leskelä S; Longo F; Caminoa A; Santón A; Ferreiro R; Pizarro D; Palacios-Berraquero ML; Palacios J
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435234
[TBL] [Abstract][Full Text] [Related]
16. Constitutional MLH1 Methylation Is a Major Contributor to Mismatch Repair-Deficient, MLH1-Methylated Colorectal Cancer in Patients Aged 55 Years and Younger.
Hitchins MP; Dámaso E; Alvarez R; Zhou L; Hu Y; Diniz MA; Pineda M; Capella G; Pearlman R; Hampel H
J Natl Compr Canc Netw; 2023 Jul; 21(7):743-752.e11. PubMed ID: 37433431
[TBL] [Abstract][Full Text] [Related]
17. An Evaluation of the Immunohistochemical Expression of Mismatch Repair Proteins (MSH2, MSH6, MLH1, and PMS2) in Prostate Adenocarcinoma.
Javeed S; Chughtai A; Zafar G; Khalid F; Batool A; Chughtai AS
Cureus; 2022 Jul; 14(7):e27448. PubMed ID: 36051725
[TBL] [Abstract][Full Text] [Related]
18. The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells.
Bommi PV; Bowen CM; Reyes-Uribe L; Wu W; Katayama H; Rocha P; Parra ER; Francisco-Cruz A; Ozcan Z; Tosti E; Willis JA; Wu H; Taggart MW; Burks JK; Lynch PM; Edelmann W; Scheet PA; Wistuba II; Sinha KM; Hanash SM; Vilar E
Cancer Res; 2021 May; 81(10):2760-2773. PubMed ID: 34003775
[TBL] [Abstract][Full Text] [Related]
19. Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.
Kim H; Lim KY; Park JW; Kang J; Won JK; Lee K; Shim Y; Park CK; Kim SK; Choi SH; Kim TM; Yun H; Park SH
Lab Invest; 2022 Feb; 102(2):160-171. PubMed ID: 34848827
[TBL] [Abstract][Full Text] [Related]
20. Reporting Subclonal Immunohistochemical Staining of Mismatch Repair Proteins in Endometrial Carcinoma in the Times of Ever-Changing Guidelines.
Scheiderer A; Riedinger C; Kimball K; Kilgore L; Orucevic A
Arch Pathol Lab Med; 2022 Sep; 146(9):1114-1121. PubMed ID: 34979565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
